US HB3810 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on June 5 2023 - 25% progression
Action: 2023-06-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 5 2023 - 25% progression
Action: 2023-06-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.
Title
Drug Origin Transparency Act of 2023
Sponsors
| Rep. Anna Eshoo [D-CA] | Rep. John Sarbanes [D-MD] | Rep. Angela Craig [D-MN] | Rep. Scott Peters [D-CA] |
| Rep. Tony Cardenas [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-06-09 | House | Referred to the Subcommittee on Health. |
| 2023-06-05 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-06-05 | House | Introduced in House |
Same As/Similar To
HB4697 (Related) 2023-07-21 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/3810/all-info |
| Text | https://www.congress.gov/118/bills/hr3810/BILLS-118hr3810ih.pdf |
